Literature DB >> 28322599

DissolvIt: An In Vitro Method for Simulating the Dissolution and Absorption of Inhaled Dry Powder Drugs in the Lungs.

Per Gerde1,2, Maria Malmlöf1,2, Lina Havsborn1, Carl-Olof Sjöberg3, Pär Ewing4, Stefan Eirefelt5, Katarina Ekelund5.   

Abstract

The main purpose of this work was to develop an in vitro method for simulating the dissolution and absorption of inhaled dry powder drugs that also mimics systemic pharmacokinetic data. A second purpose was to evaluate this method. DissolvIt® was developed as a simulation of the air-blood barrier of the upper airways, constituting: "airborne" particles deposited on a glass cover slip, a mucus simulant, a polycarbonate (basal) membrane, and a pumped albumin buffer simulating the pulmonary blood flow. The PreciseInhale® exposure system was used to aerosolize and deposit test formulations onto cover slips. The particle dissolution was observed by optical microscopy as particle disappearance, and it was started directly when the particles came into contact with the mucus simulant. Solute from the dissolving particles diffused through the barrier and was absorbed into the perfusate. The drug concentration in the perfusate over time and the remaining drug in the barrier at the end of the experiment were quantitated by using liquid chromatography-tandem mass spectrometry. Budesonide and fluticasone propionate generated different pharmacokinetic dissolution/absorption profiles in DissolvIt. This study indicates that DissolvIt simulates dissolution and absorption of drugs in the lung, and that DissolvIt also mimics pharmacokinetic profiles and parameters.

Entities:  

Keywords:  aerosol generation; dissolution testing; dry powder; in vitro dissolution method; inhalation; lung dissolution

Mesh:

Substances:

Year:  2017        PMID: 28322599     DOI: 10.1089/adt.2017.779

Source DB:  PubMed          Journal:  Assay Drug Dev Technol        ISSN: 1540-658X            Impact factor:   1.738


  5 in total

1.  Adapting the Aerogen Mesh Nebulizer for Dried Aerosol Exposures Using the PreciseInhale Platform.

Authors:  Per Gerde; Mattias Nowenwik; Carl-Olof Sjöberg; Ewa Selg
Journal:  J Aerosol Med Pulm Drug Deliv       Date:  2019-10-15       Impact factor: 2.849

2.  A STELLA simulation model for in vitro dissolution testing of respirable size particles.

Authors:  Basanth Babu Eedara; Ian G Tucker; Shyamal C Das
Journal:  Sci Rep       Date:  2019-12-06       Impact factor: 4.379

3.  Characterization of Membrane-Type Dissolution Profiles of Clinically Available Orally Inhaled Products Using a Weibull Fit and a Mechanistic Model.

Authors:  Irès van der Zwaan; Frans Franek; Rebecca Fransson; Ulrika Tehler; Göran Frenning
Journal:  Mol Pharm       Date:  2022-08-08       Impact factor: 5.364

4.  Use of PBPK Modeling To Evaluate the Performance of Dissolv It, a Biorelevant Dissolution Assay for Orally Inhaled Drug Products.

Authors:  Mireille Hassoun; Maria Malmlöf; Otto Scheibelhofer; Abhinav Kumar; Sukhi Bansal; Ewa Selg; Mattias Nowenwik; Per Gerde; Snezana Radivojev; Amrit Paudel; Sumit Arora; Ben Forbes
Journal:  Mol Pharm       Date:  2019-02-15       Impact factor: 4.939

5.  Model for the Analysis of Membrane-Type Dissolution Tests for Inhaled Drugs.

Authors:  Göran Frenning; Irès van der Zwaan; Frans Franek; Rebecca Fransson; Ulrika Tehler
Journal:  Mol Pharm       Date:  2020-06-15       Impact factor: 4.939

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.